This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Arch Ophthalmol. 2001;119:1079-1080.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Vasovagal reactions (VVRs) can present a treatment dilemma for medical professionals, and fear of causing such reactions can prevent ophthalmologists from performing necessary examinations. Atenolol, midodrine hydrochloride, paroxetine, fludrocortisone acetate, as well as salt and fluid intake have demonstrated efficacy in treating the disorder.¹ Other vasoconstrictors and selective serotonin reuptake inhibitors are being studied, but to our knowledge, there are no medications to prevent isolated incidents of VVR with known triggers.² We describe 2 patients who experienced VVRs on applanation tonometry or instillation of dilating drops. Subsequent reactions were prevented with oral Atrohist Plus (a combination of phenylephrine hydrochloride, phenylpropanolamine hydrochloride, chlorpheniramine maleate, hyoscyamine sulfate, atropine sulfate, and scopolamine hydrobromide; Vintage Pharmaceuticals Inc, Charlotte, NC) administered 1 hour prior to examination.

Report of Cases

Case 1

A 41-year-old healthy man with an ocular history of myopia and a family history of glaucoma was seen for complaints of decreased visual acuity for several months. After instillation . . . [Full Text of this Article]

Case 2

Comment
Corresponding author: Norbert Becker, MD, Cook County Hospital, 1835 W Harrison, Chicago, IL 60612(e-mail: www.genevaeye.com).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?